EXHIBIT A FORM OF VOTING AGREEMENTVoting Agreement • November 18th, 2003 • Genome Therapeutics Corp • In vitro & in vivo diagnostic substances • Delaware
Contract Type FiledNovember 18th, 2003 Company Industry JurisdictionVOTING AGREEMENT, dated as of November , 2003 (this “Agreement”), between Genome Therapeutics Corp., a Massachusetts corporation (“Parent”) and [name of stockholder] (“Stockholder”).
AGREEMENT AND PLAN OF MERGER AND REORGANIZATION among GENOME THERAPEUTICS CORP., GUARDIAN ACQUISITION, INC., GENESOFT PHARMACEUTICALS, INC. and LUKE EVNIN, as STOCKHOLDERS’ REPRESENTATIVE (solely for purposes of Section 9.05) Dated as of November 17, 2003Merger Agreement • November 18th, 2003 • Genome Therapeutics Corp • In vitro & in vivo diagnostic substances • New York
Contract Type FiledNovember 18th, 2003 Company Industry JurisdictionAGREEMENT AND PLAN OF MERGER AND REORGANIZATION, dated as of November 17, 2003 (this “Agreement”), among Genome Therapeutics Corp., a Massachusetts corporation (“Parent”), Guardian Acquisition, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”), Genesoft Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Luke Evnin, as Stockholders’ Representative (as defined in Section 9.05 hereof and solely for purposes thereof).